Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals...
15 KB (1,249 words) - 00:09, 27 August 2024
pathway by gefitinib tumor growth was decreased both in vitro and in vivo. Sarilumab was approved by US FDA in 2017 for rheumatoid arthritis. Several agents...
12 KB (1,289 words) - 19:20, 4 December 2023
FDA in March 2017 and is reported to cost $37,000 per year. Kevzara (sarilumab injection) is an interleukin-6 (IL-6) receptor antagonist for treatment...
26 KB (2,290 words) - 23:04, 12 September 2024
Pharmaceuticals. Jevtana (Cabazitaxel), for prostate cancer. Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron. Libtayo...
92 KB (8,810 words) - 04:11, 13 September 2024
Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab...
3 KB (367 words) - 15:37, 25 January 2024
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin...
22 KB (1,789 words) - 04:29, 16 July 2024
saralasin (INN) sarcolysin (INN) saredutant (INN) Sarenin sargramostim (INN) sarilumab (USAN) saripidem (INN) Sarisol sarizotan (USAN) sarmazenil (INN) sarmoxicillin...
6 KB (341 words) - 15:24, 20 March 2022
Pirfenidone Ponesimod Ravulizumab Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab Siltuximab Siponimod Sirukumab Spesolimab Sutimlimab Tildrakizumab...
7 KB (299 words) - 13:45, 27 April 2024
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin...
35 KB (2,793 words) - 23:27, 30 September 2024
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin...
22 KB (2,581 words) - 20:03, 21 June 2024